Insiders · Profile

Hackman Jeffrey S.

Chief Executive Officer at FENNEC PHARMACEUTICALS. Filing since 16 May 2025. CIK 0001926254

Company
Date
Role
Action
Shares
Amount
Of holding
19 May 2025
Chief Executive Officer
Bought
13,965
$97.62K
×13
16 May 2025
Chief Executive Officer
Bought
1,035
$6.99K
opened
2 decisions on file.